By the Phase-III opening boundary, the subject is wearing the Office's standard instrument suite: a wrist-band carrying optical heart-rate and skin-temperature sensors, an ear-bud carrying audio-affective baseline capture, and a posture-tracking adhesive at the lumbar region. The suite is marketed to the subject as a wellness kit. The suite is, in fact, the Office's Phase-III continuous-capture instrument for the subject's autonomic and behavioral streams.
The subject does not perceive the wearable suite as surveillance. The suite is socially expected; peers compare scores; cohort norms have been established. A subject without the suite is anomalous, and the Office records the absence as a separate Phase-III indicator (see sub-protocol 3.2 on out-of-bounds response).
The subject opens the Wellness Dashboard at the rate of roughly thirty-two times per day. The dashboard presents the aggregate of the day's instrument streams as a single Wellness Score, with sub-scores for the major sub-categories. A specimen is shown below.
Fig. 3.5.A — Specimen Wellness Dashboard, evening view
The Phase-III subject learns to interpret the dashboard as authoritative on their own interior state. A subject who feels alert but whose dashboard reports an elevated cortisol baseline is taught to defer to the dashboard; their alertness is reclassified as a stress reaction. A subject who feels sluggish but whose dashboard reports optimal sleep-quality is taught to push through; their sluggishness is reclassified as a perceptual error.
The Office considers the dashboard's authority over the subject's self-perception to be among Phase III's most important deliverables. A subject who consults the dashboard before consulting their own body has installed the lifelong quantification posture under which Phases IV through VII operate. The subject's body, in turn, gradually atrophies as a primary source of self-knowledge.
The Composite Wellness Score is computed from sleep, activity, autonomic arousal, mood-self-report, social connectivity (counted in dashboard-mediated interactions), and substance compliance (Phase-III subjects on the Substance Schedule contribute medication-adherence to their score). Subjects compete on Composite Wellness within their peer cohort. The Office's brand partners receive de-identified score distributions as part of the quarterly data-sharing agreement.
Cohort leaderboards are published quarterly. Top-decile subjects receive Phase-III Wellness Distinction, a badge that accrues to the Phase-IV onboarding profile. Bottom-decile subjects are routed into the Phase-III Wellness Calibration Pathway. Most pathway entrants return to median within a single quarter.